Effect of diabetes mellitus on prognosis and development of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis

Aim: Hepatitis C virus (HCV) infection and diabetes mellitus (DM) negatively affect each other. HCV patients diagnosed with DM havemore complications than patients with HCV infection alone. In this study, we aimed to investigate the effect of DM on complicationrate, hepatocellular cancer (HCC) development and mortality in HCV RNA (+) cirrhosis patients.Material and Methods: Patients admitted with Hepatitis C-related cirrhosis and followed up for at İzmir Katip Çelebi UniversityAtatürk Training and Research Hospital Gastroenterology and Internal Medicine Clinic for at least six months between 2005and 2014were retrospectively evaluated.Results: A total of 146 patients with HCV-related cirrhosis were included in the study. Of these patients, 53 (36.3%) had diagnosisof DM. In 108 patients who did not develop hepatocellular carcinoma (HCC), the mean CHILD score at final admission (p=0.024),difference between mean CHILD scores at final and initial admission (p=0.011), and annual rate of increase in CHILD score (p=0.047)was significantly higher in the DM group. There was no significant difference between the DM and non-DM groups according to bothoverall survival (p=0.115) and time of HCC development (p=0.567).Conclusion: While HCC development and overall survival were similar in both groups, in the subgroup of patients who did not developHCC, the annual increase in CHILD score and final CHILD score were significantly higher in DM patients.

PDF

___

1. Davis GL, Albright JE, Cook SF. Projecting future complications of chronic hepatitis C in the United States. Liver Transpl 2003;9:3318.
2. Global surveillance and control of hepatitis C. Report of a WHO consultation organized in collaboration with the viral hepatitis prevention board, antwerp, belgium. J Viral Hepat 1999;6:3547.
3. WHO. Hepatitis C: Fact sheet N°164.
4. Serfaty L. Metabolic Manifestations of hepatitis c virus: diabetes mellitus, dyslipidemia. Clin Liver Dis 2017;21:475-86.
5. Noto H, Raskin P. Hepatitis C infection and diabetes. J Diabetes Complications 2006;20:113-20.
6. Elkrief L, Rautou PE, Sarin S. Diabetes mellitus in patients with cirrhosis: clinical implications and management. Liver Int 2016;36:936-48.
7. de Marco R, Locatelli F, Zoppini G. Cause-specific mortality in type 2 diabetes. The Verona diabetes study. Diabetes Care 1999;22:756–61.
8. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004;126:460–8.
9. Zoppini G, Fedeli U, Gennaro N. Mortality from chronic liver diseases in diabetes. Am J Gastroenterol 2014;109:1020–5.
10. Seki E, Schwabe RF. Hepatic inflammation and fibrosis: functional links and key pathways. Hepatology 2015;61:1066–79.
11. Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 2011;11:98– 107.
12. Petta S, Camma C, Marco VD, et al. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection. Am J Gastroenterol 2008;103:1136–44.
13. Ghany MG, Kleiner DE, Alter H, et al. Progression of fibrosis in chronic hepatitis C. Gastroenterology 2003;124:97–104.
14. Stanley S. Schwartz, Struan FA. et al. Intersections and clinical translations of diabetes mellitus with cancer promotion, progression and prognosis, Postgraduate Medicine. Accepted article: August 15, 2019. Published online: Sep 5,2019.
15. Dyal HK, Aguilar M, Bartos G, et al. Diabetes mellitus increases risk of hepatocellular carcinoma in chronic hepatitis C virus patients: a systematic review. Dig Dis Sci 2016;61:636-45.
16. Desbois AC, Cacoub P. Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review. 2017;23:1697-711.
17. Perz JF, Armstrong GL, Farrington LA. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006;45:529–38.
18. Wang YG, Wang P, Wang B. Diabetes mellitus and poorer prognosis in hepatocellular carcinoma: a systematic review and metaanalysis. PloS ONE 2014;15;9:95485.
19. Huang, Lin TS, Shyu CL, Chiu YC, et al. Diabetes, hepatocellular carcinoma, and mortality in hepatitis C-infected patients: A population-based cohort study. J Gastroenterol Hepatol 2016;32:1355–62.
20. Li X, Xu H, Gao Y, et al. Diabetes mellitus increases the risk of hepatocellular carcinoma in treatmentnaive chronic hepatitis C patients in China. Medicine 2017;96:6508.
21. Davila JA, Morgan RO, Shaib Y. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut. 2005;54:533–9.
22. Veldt BJ, Chen W, Heathcote EJ, et al. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology 2008;47:1856–62.
23. Tazawa J, Maeda M, Nakagawa M, et al. Diabetes mellitus may be associated with hepatocarcinogenesis in patients with chronic hepatitis C. Dig Dis Sci 2002;47:710-5.
24. Lai MS, Hsieh MS, Chiu YH. Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection. Hepatology 2006;43:1295–302.
25. Petrides AS, Stanley T, Matthews DE, et al. Insulin resistance in cirrhosis: prolonged reduction of hyperinsulinemia normalizes insulin sensitivity. Hepatology 1998;28:141-9.
26. Holstein A, Hinze S, Thiessen E. Clinical implications of hepatogenous diabetes in liver cirrhosis. J Gastroenterol Hepatol 2002;17:677-81.
27. Roden M. Mechanisms of Disease: hepatic steatosis in type 2 diabetes pathogenesis and clinical relevance. Nat Clin Pract Endocrinol Metab 2006;2:335-48.
28. Trombetta M, Spiazzi G, Zoppini G. Review article: type 2 diabetes and chronic liver disease in the Verona diabetes study. Aliment Pharmacol Ther 2005;2:24-7.
29. Quintana JO, García-Compean D, González JA, et al. The impact of diabetes mellitus in mortality of patients with compensated liver cirrhosis a prospective study. Ann Hepatol 2011;10:56-62.